Name: Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics (Volume 42-2) (The Clinics: Internal Medicine, Volume 42-2) (en Inglés)
Price: 317336.00 COP
Availability: InStock
Author: Arjun Balar Md
ISBN: 9780323376235

portada Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics (Volume 42-2) (The Clinics: Internal Medicine, Volume 42-2) (en Inglés)

Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics (Volume 42-2) (The Clinics: Internal Medicine, Volume 42-2) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier 2015-05-28,

Autor

Arjun Balar Md

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323376235

Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics (Volume 42-2) (The Clinics: Internal Medicine, Volume 42-2) (en Inglés)

Arjun Balar Md (Autor) · Elsevier 2015-05-28, · Tapa Dura

Libro Nuevo Importado

Envío: 18 a 22 días háb.

$ 528.893$ 317.336

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 317.336

¡Envío Gratis! Llega entre el 20 Ago y el 27 Ago a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics (Volume 42-2) (The Clinics: Internal Medicine, Volume 42-2) (en Inglés)"

The Guest Editors have assembled top key opinion leaders to provide current reviews on the multidisciplinary approach to the management of high-grade bladder cancer. Articles are devoted to fluorescence cystoscopy, confocal laser endomicroscopy, narrow band imaging; Novel therapeutic approaches for recurrent nonmuscle invasive bladder cancer; Trimodality therapy in bladder cancer; the data and the reality of perioperative chemotherapy in muscle invasive bladder cancer; radical transurethral resection alone, robotic or partial cystectomy or extended lymphadenectomy: Neoadjuvant paradigm for drug development in muscle invasive bladder cancer; Novel biomarkers to predict response and prognosis in localized bladder cancer; Immunotherapy in Advanced/Metastatic Urothelial Cancer; and Adjuvant Chemotherapy in High Grade Upper Tract Urothelial Cancer.